Literature DB >> 16315135

Pathophysiology of hereditary hemochromatosis.

Robert E Fleming1, Robert S Britton, Abdul Waheed, William S Sly, Bruce R Bacon.   

Abstract

Hereditary hemochromatosis (HH) encompasses several inherited disorders of iron homeostasis characterized by increased gastrointestinal iron absorption and tissue iron deposition. The most common form of this disorder is HFE-related HH, nearly always caused by homozygosity for the C282Y mutation. A substantial proportion of C282Y homozygotes do not develop clinically significant iron overload, suggesting roles for environmental factors and modifier genes in determining the phenotype. Recent studies have demonstrated that the pathogenesis of nearly all forms of HH involves inappropriately decreased expression of the iron-regulatory hormone hepcidin. Hepcidin serves to decrease the export of iron from reticuloendothelial cells and absorptive enterocytes. Thus, HH patients demonstrate increased iron release from these cell types, elevated circulating iron, and iron deposition in vulnerable tissues. The mechanism by which HFE influences hepcidin expression is an area of current investigation and may offer insights into the phenotypic variability observed in persons with mutations in HFE.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16315135      PMCID: PMC2587012          DOI: 10.1055/s-2005-923313

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  94 in total

1.  Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.

Authors:  Elizabeta Nemeth; Erika V Valore; Mary Territo; Gary Schiller; Alan Lichtenstein; Tomas Ganz
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

Review 2.  African iron overload.

Authors:  Victor R Gordeuk
Journal:  Semin Hematol       Date:  2002-10       Impact factor: 3.851

3.  Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis.

Authors:  Gaël Nicolas; Lydie Viatte; Dan-Qing Lou; Myriam Bennoun; Carole Beaumont; Axel Kahn; Nancy C Andrews; Sophie Vaulont
Journal:  Nat Genet       Date:  2003-05       Impact factor: 38.330

4.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Authors:  Gaël Nicolas; Caroline Chauvet; Lydie Viatte; Jean Louis Danan; Xavier Bigard; Isabelle Devaux; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.

Authors:  Kim R Bridle; David M Frazer; Sarah J Wilkins; Jeanette L Dixon; David M Purdie; Darrell H G Crawford; V Nathan Subramaniam; Lawrie W Powell; Gregory J Anderson; Grant A Ramm
Journal:  Lancet       Date:  2003-02-22       Impact factor: 79.321

6.  Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis.

Authors:  Robert E Fleming; John R Ahmann; Mary C Migas; Abdul Waheed; H Phillip Koeffler; Hiroshi Kawabata; Robert S Britton; Bruce R Bacon; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-19       Impact factor: 11.205

7.  Hepcidin, a new iron regulatory peptide.

Authors:  Gaël Nicolas; Lydie Viatte; Myriam Bennoun; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  Blood Cells Mol Dis       Date:  2002 Nov-Dec       Impact factor: 3.039

8.  Decreased liver hepcidin expression in the Hfe knockout mouse.

Authors:  Kaashif A Ahmad; John R Ahmann; Mary C Migas; Abdul Waheed; Robert S Britton; Bruce R Bacon; William S Sly; Robert E Fleming
Journal:  Blood Cells Mol Dis       Date:  2002 Nov-Dec       Impact factor: 3.039

9.  Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats.

Authors:  David M Frazer; Sarah J Wilkins; Erika M Becker; Christopher D Vulpe; Andrew T McKie; Deborah Trinder; Gregory J Anderson
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

10.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.

Authors:  Antonella Roetto; George Papanikolaou; Marianna Politou; Federica Alberti; Domenico Girelli; John Christakis; Dimitris Loukopoulos; Clara Camaschella
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

View more
  16 in total

1.  Iron-mediated retinal degeneration in haemojuvelin-knockout mice.

Authors:  Jaya P Gnana-Prakasam; Amany Tawfik; Michelle Romej; Sudha Ananth; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem J       Date:  2012-01-15       Impact factor: 3.857

2.  Polarized distribution of heme transporters in retinal pigment epithelium and their regulation in the iron-overload disease hemochromatosis.

Authors:  Jaya P Gnana-Prakasam; Sushma K Reddy; Rajalakshmi Veeranan-Karmegam; Sylvia B Smith; Pamela M Martin; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

3.  Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe.

Authors:  Elena Corradini; Molly Rozier; Delphine Meynard; Adam Odhiambo; Herbert Y Lin; Qi Feng; Mary C Migas; Robert S Britton; Jodie L Babitt; Robert E Fleming
Journal:  Gastroenterology       Date:  2011-07-13       Impact factor: 22.682

4.  Loss of Hfe leads to progression of tumor phenotype in primary retinal pigment epithelial cells.

Authors:  Jaya P Gnana-Prakasam; Rajalakshmi Veeranan-Karmegam; Veena Coothankandaswamy; Sushma K Reddy; Pamela M Martin; Muthusamy Thangaraju; Sylvia B Smith; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

5.  Expression and iron-dependent regulation of succinate receptor GPR91 in retinal pigment epithelium.

Authors:  Jaya P Gnana-Prakasam; Sudha Ananth; Puttur D Prasad; Ming Zhang; Sally S Atherton; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

6.  SLC39A14 Is Required for the Development of Hepatocellular Iron Overload in Murine Models of Hereditary Hemochromatosis.

Authors:  Supak Jenkitkasemwong; Chia-Yu Wang; Richard Coffey; Wei Zhang; Alan Chan; Thomas Biel; Jae-Sung Kim; Shintaro Hojyo; Toshiyuki Fukada; Mitchell D Knutson
Journal:  Cell Metab       Date:  2015-05-28       Impact factor: 27.287

7.  Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.

Authors:  Wei-Hong Hou; Lisa Rossi; Ying Shan; Jian-Yu Zheng; Richard-W Lambrecht; Herbert-L Bonkovsky
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

8.  Absence of iron-regulatory protein Hfe results in hyperproliferation of retinal pigment epithelium: role of cystine/glutamate exchanger.

Authors:  Jaya P Gnana-Prakasam; Muthusamy Thangaraju; Kebin Liu; Yonju Ha; Pamela M Martin; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem J       Date:  2009-11-11       Impact factor: 3.857

Review 9.  Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance.

Authors:  Yutaka Kohgo; Katsuya Ikuta; Takaaki Ohtake; Yoshihiro Torimoto; Junji Kato
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

10.  Global transcriptional response to Hfe deficiency and dietary iron overload in mouse liver and duodenum.

Authors:  Alejandra Rodriguez; Tiina Luukkaala; Robert E Fleming; Robert S Britton; Bruce R Bacon; Seppo Parkkila
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.